Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma
Washington University School of Medicine
Washington University School of Medicine
University of Chicago
Institute of Hematology & Blood Diseases Hospital, China
Eli Lilly and Company
Janssen Research & Development, LLC
Universität des Saarlandes
Incyte Corporation
PrECOG, LLC.
University of Miami
Celgene
Janssen Research & Development, LLC
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
The Lymphoma Academic Research Organisation
Cyteir Therapeutics, Inc.
University of Nebraska
University of Giessen
Weill Medical College of Cornell University
City of Hope Medical Center
City of Hope Medical Center
University of Nebraska
University of Nebraska
Celgene
Washington University School of Medicine
University of Nebraska
University of Nebraska
University of Nebraska
City of Hope Medical Center
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Brown University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Fondazione Italiana Linfomi - ETS
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
SWOG Cancer Research Network
SWOG Cancer Research Network
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Universität des Saarlandes
SymBio Pharmaceuticals
Universität des Saarlandes
Gilead Sciences
German High-Grade Non-Hodgkin's Lymphoma Study Group
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Lund University Hospital
Fred Hutchinson Cancer Center